3D Bioprinting logo
  • HOME
  • INFO
    • SPEAKERS
    • AGENDA
  • LOCATION
    • VENUE
  • SPONSORS
  • CONTACT US
Twitter

Printing the Future of Therapeutics in 3D

Spring 2023 in Vancouver, BC, Canada

Hosted and organized by

FOSTERING RELATIONSHIPS AND DEVELOPING COLLABORATIONS

PFT3D is an exclusive roundtable event centred around facilitating discussion and collaboration on the development of commercially and clinically relevant life-saving tissues.

SYMPOSIUM INFORMATION

Aspect Biosystems and The University of British Columbia are proud to be co-organizing the fourth annual international symposium on Printing the Future of Therapeutics in 3D (PFT3D).

Last year’s inaugural event saw speakers from a wide variety of both academia and industry to discuss the amazing potential and applications of 3D bioprinting. This year, the event will take place over 3 days and includes 20 speakers, covering four key areas:

Functional biofabricated tissues for disease modeling, therapeutic discovery, and regenerative medicine
Platform technologies to recreate biological function
Biomaterials for the development of functional tissues
An industry perspective on tissue engineering technologies

By the end of this meeting, we want you to leave with new inspirational ideas on groundbreaking projects, new partners and opportunities for collaboration, and a fresh perspective on the needs of industry and the translation of academic research.

In addition to our roundtable talks, there will be focused discussion sessions to address a variety of key challenges in our industry and facilitated networking sessions to stimulate interactions.

2020 SPEAKERS & PANELLISTS

(more to be announced)

Organizing Committee

Tamer Mohamed

Tamer Mohamed

President & CEO, Aspect Biosystems
Peter Zandstra

Peter Zandstra

Director & Professor, UBC School of Biomedical Engineering
Sam Wadsworth

Sam Wadsworth

Chief Scientific Officer, Aspect Biosystems
Natalie Korenic

Natalie Korenic

Marketing & Communications Manager, Aspect Biosystems

Speakers & Panellists

Luis Alvarez

Luis Alvarez

Director, Organ Manufacturing, United Therapeutics
Greg Block

Greg Block

Director of Business Development, Astellas Pharma
Jonas Christoffersson

Jonas Christoffersson

Post-Doctoral Fellow, University of Skövde, Sweden
Jason Dowd

Jason Dowd

Vice President, Science & Technology, CCRM
Anne-Marie Fortier

Anne-Marie Fortier

Research Associate, Goodman Cancer Research Centre, McGill University
Spiro Getsios

Spiro Getsios

VP, Tissue Engineering, Aspect Biosystems
Manuel Gomez-Florit

Manuel Gomez-Florit

Junior Researcher, 3B’s Research Group, University of Minho
Daniel A. Harrington

Daniel A. Harrington

Assistant Professor, School of Dentistry, University of Texas Health Science Center at Houston
Ola Hermanson

Ola Hermanson

Senior Researcher, Department of Neuroscience, Karolinska Institutet, Sweden
Ali Khademhosseini

Ali Khademhosseini

Director & Professor, Centre for Minimally Invasive Therapeutics, University of California at Los Angeles
Timothy J. Kieffer

Timothy J. Kieffer

Professor, Cellular & Physiological Sciences and Surgery, Diabetes Research Group Leader, University of British Columbia
Betty Li

Betty Li

Post-Doctoral Fellow, Human Health Therapeutics Research Centre, National Research Council of Canada
Eva Loo

Eva Loo

Project House Tissue Engineering, Evonik Asia Research Hub
Geoff Mackay

Geoff Mackay

President and CEO, AVROBIO, Inc.
Carlos Mota

Carlos Mota

Assistant Professor, Maastricht University, MERLN Institute, Dept. of Complex Tissue Regeneration, The Netherlands
Glen Tibbits

Glen Tibbits

Professor & Chair, Biomedical Physiology and Kinesiology, Simon Fraser University
Adrian West

Adrian West

Assistant Professor, Department of Physiology and Pathophysiology, University of Manitoba
Peter Zandstra

Peter Zandstra

Director & Professor, UBC School of Biomedical Engineering

2019 SPEAKERS & PANELLISTS

  • Nureddin Ashammakhi
    Co-Director, Institute for Minimally Invasive Therapeutics, David Geffen School of Medicine, UCLA
  • R. Lee Buckler
    President & CEO, RepliCel Life Sciences, Inc.
  • Heather Burkin
    Assistant Professor, Department of Pharmacology University of Nevada, Reno School of Medicine
  • Jason Ekert
    Head Complex In Vitro Models, In Vitro/In Vivo Translation, Research, GlaxoSmithKline
  • Spiro Getsios
    VP, Tissue Engineering, Aspect Biosystems
  • Paul C. Goodwin
    Science Director, GE Healthcare, Life Sciences
  • Ken-ichi Hamada
    Program Manager, JSR-Keio University Medical and Chemical Innovation Center, JSR Corporation
  • Jinah Jang
    Assistant Professor, Pohang University of Science and Technology (POSTECH)
  • Anna Jezierski
    Research Scientist, Human Health Therapeutics, National Research Council Canada
  • Timothy J. Kieffer
    Professor, Cellular & Physiological Sciences and Surgery, University of British Columbia, Diabetes Research Group Leader, School of Biomedical Engineering, Life Sciences Institute
  • Todd A. Lorenz
    Partner, Intellectual Property & Technology, Squire Patton Boggs
  • Faisal M. Mirza
    Surgeon, Artist, Author, Entrepreneur, OrthoSynthesis Inc.
  • Carlos Mota
    Assistant Professor, Maastricht University, MERLN Institute, Dept. of Complex Tissue Regeneration, The Netherlands
  • Massimiliano Paganelli
    Pediatric Hepatologist, Sainte-Justine University Hospital Center, Assistant Professor of Pediatrics, Université de Montréal, Founder, Morphocell Technologies Inc.
  • Fabio Rossi
    Professor, Medical Genetics and Biomedical Engineering, University of British Columbia, Director of the Biomedical Research Centre and Director of Research of the School of Biomedical Engineering
  • Venu Varanasi
    Associate Professor, Department of Graduate Nursing, Department of Materials Science and Engineering, University of Texas at Arlington
  • Adrian West
    Assistant Professor, Department of Physiology and Pathophysiology, University of Manitoba
  • Stephanie Willerth
    Associate Professor and Canada Research Chair in Biomedical Engineering, University of Victoria
  • Tim Woodfield
    Assoc Professor, University of Otago, New Zealand Director CReaTE Group, Department of Orthopaedic Surgery Director UOtago Centre for Bioengineering & Nanomedicine
  • Yu Shrike Zhang
    Assistant Professor, Department of Medicine, Harvard Medical School

2020 AGENDA

Over the two days, we will have influential innovators from around the world discussing the latest technological advances and challenges of bioprinting living human tissues.

Last year’s program can be downloaded HERE.

Monday, May 4

5:00pm: Welcome Reception – Downtown Vancouver

Tuesday, May 5

8:15-9:00am: Breakfast & Registration
9:00-4:00pm: Talks & Interactive Discussion
5:00pm: informal eats and drinks on campus OR
shuttle departs for Speakers’ Reception (invite only)

Wednesday, May 6

8:15-9:00am: Breakfast
9:00am onward: Talks, Panel & Interactive Discussion
Late afternoon: Close of PFT3D 2020 (exact time TBA)

Location

VENUE & HOSTS

We are proud to be hosting this International Research Roundtable at the Peter Wall Institute for Advanced Studies on the beautiful University of British Columbia (UBC) campus in Vancouver, BC.

Aspect Biosystems is a privately held biotechnology company pioneering microfluidic 3D bioprinting of living, human tissue. The company’s proprietary technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to enable the creation of living, human tissues for medical research, therapeutic discovery, and regenerative medicine products.

The School of Biomedical Engineering at the University of British Columbia was established in 2017. We are founded through partnerships with more than 20 joint faculty members that are leaders in research areas from molecular and cellular engineering, to biological imaging, computational biology and human interfacing devices. With access to world-leading research infrastructure, and with close partnerships with our research intensive hospitals and local industry, the School aims to provide a clear route from the discovery of new fundamental biomedical technologies to their innovative application and development to benefit human health.

The University of British Columbia is a global centre for research and teaching, consistently ranked among the 40 best universities in the world. Since 1915, UBC’s West Coast spirit has embraced innovation and challenged the status quo. Its entrepreneurial perspective encourages students, staff and faculty to challenge convention, lead discovery and explore new ways of learning. At UBC, bold thinking is given a place to develop into ideas that can change the world.

Peter Wall Institute for Advanced Studies Logo

The Peter Wall Institute for Advanced Studies at the University of British Columbia (UBC) provides funding opportunities and an intellectual environment scholars are free to pursue the collaborative exchange of ideas beyond disciplinary boundaries.

The Institute’s goal is to stimulate creative, innovative research that makes important advances in knowledge, and to share or implement these ideas through ongoing community engagement. The Institute achieves this by supporting a highly collaborative environment at UBC where scholars have the opportunity to exchange ideas with national and international scholars, develop new thinking and engage in intellectual risk-taking.

2020 SPONSORS

Thank you to all our sponsors!

UBC Faculty of Medicine Logo

CONTACT US

University of British Columbia, Vancouver, BC

Natalie Korenic:+604 263-0502

nataliek@aspectbiosystems.com

© 2017 3d-bioprinting.ca | Website design by Myron